Search

Your search keyword '"Laforet, Pascal"' showing total 222 results

Search Constraints

Start Over You searched for: Author "Laforet, Pascal" Remove constraint Author: "Laforet, Pascal" Language english Remove constraint Language: english
222 results on '"Laforet, Pascal"'

Search Results

2. Correction to: Analysis of muscle magnetic resonance imaging of a large cohort of patient with VCP‑mediated disease reveals characteristic features useful for diagnosis

3. Analysis of muscle magnetic resonance imaging of a large cohort of patient with VCP-mediated disease reveals characteristic features useful for diagnosis

5. Hypersensitivity infusion-associated reactions induced by enzyme replacement therapy in a cohort of patients with late-onset Pompe disease: An experience from the French Pompe Registry

6. Cardiac Outcomes in Adults With Mitochondrial Diseases

9. Start, switch and stop (triple‐S) criteria for enzyme replacement therapy of late‐onset Pompe disease: European Pompe Consortium recommendation update 2024.

10. Clinical practice guidelines for glycogen storage disease V & VII (McArdle disease and Tarui disease) from an international study group

11. Safety and efficacy of cipaglucosidase alfa plus miglustat versus alglucosidase alfa plus placebo in late-onset Pompe disease (PROPEL): an international, randomised, double-blind, parallel-group, phase 3 trial

12. Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial

13. Home-based exercise in autoimmune myasthenia gravis: A randomized controlled trial

14. Sirolimus for treatment of patients with inclusion body myositis: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2b trial

15. European muscle MRI study in limb girdle muscular dystrophy type R1/2A (LGMDR1/LGMD2A)

23. FSHD1 and FSHD2 form a disease continuum

26. Dermatomyositis With or Without Anti-Melanoma Differentiation-Associated Gene 5 Antibodies: Common Interferon Signature but Distinct NOS2 Expression

27. Clinical heterogeneity and phenotype/genotype findings in 5 families with GYG1 deficiency

28. Rescue of Pompe disease in mice by AAV-mediated liver delivery of secretable acid α-glucosidase

30. Affected female carriers of MTM1 mutations display a wide spectrum of clinical and pathological involvement: delineating diagnostic clues

31. Proceedings of Réanimation 2017, the French Intensive Care Society International Congress

32. Genotype-phenotype correlations in valosin-containing protein disease

36. Muscle MRI findings in limb girdle muscular dystrophy type 2L

45. Myopathy with hexagonally cross-linked crystalloid inclusions: Delineation of a clinico-pathological entity

49. Clinical outcome in 19 French and Spanish patients with valosin-containing protein myopathy associated with Paget’s disease of bone and frontotemporal dementia

50. Diagnostic assessment and long-term follow-up of 13 patients with Very Long-Chain Acyl-Coenzyme A dehydrogenase (VLCAD) deficiency

Catalog

Books, media, physical & digital resources